About CORTExBio Corporation
CORTExBio Corporation is a biotechnology company founded in 2025, focused on developing precision small-molecule drugs targeting the prefrontal cortex to enhance human cognitive capabilities. The company operates at the intersection of systems neuroscience, computational pharmacology, and translational drug discovery.
Precision small-molecule drug discoveryMechanistic understanding of prefrontal cortex circuit biologyAI-driven prioritization of molecular targetsIn silico screening and in vivo preclinical modelingDevelopment of CNS-appropriate pharmacokinetics and target selectivity
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CORTExBio Corporation right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.